Publication | Open Access
Results and insights from a phase I clinical trial of Lomecel‐B for Alzheimer's disease
66
Citations
38
References
2022
Year
Our results support the safety of Lomecel-B for AD, suggest clinical potential, and provide mechanistic insights. This early-stage study provides important exploratory information for larger efficacy-powered clinical trials.
| Year | Citations | |
|---|---|---|
Page 1
Page 1